Michael Kyriakides
Director/Board Member at Purespring Therapeutics Ltd.
Network origin in Michael Kyriakides first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Imperial College London
220
| College/University | Other Consumer Services | 220 |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.
31
| Subsidiary | Investment Managers | 31 |
Purespring Therapeutics Ltd.
 Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Kyriakides via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Private Equity Investor | |
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member | |
Connor, Clark & Lunn Investment Management Ltd.
 Connor, Clark & Lunn Investment Management Ltd. Investment ManagersFinance Connor, Clark & Lunn Investment Management Ltd. (CC&L) is an investment advisory firm headquartered in Vancouver, British Columbia with an additional office in Toronto. The firm was founded in 1982 and is a subsidiary of Connor, Clark & Lunn Investment Management Partnership, itself a subsidiary of Connor, Clark & Lunn Financial Group Ltd. CC&L provides investment management services to individuals, pension and profit-sharing plans, trusts, estates, charitable organizations, businesses and private investment funds. | Investment Managers | Analyst-Equity | |
| TOUCHSTONE INNOVATIONS PLC | Investment Managers | Director/Board Member Chairman | |
| ANAPTYSBIO, INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| SYNCONA LIMITED | Investment Trusts/Mutual Funds | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Private Equity Investor | |
| GSK PLC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
| Stanford University | College/University | Corporate Officer/Principal Graduate Degree Doctorate Degree | |
| LONZA GROUP AG | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| DECHRA PHARMACEUTICALS | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Oxford | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Graduate Degree | |
| University of Aberdeen | College/University | Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
The Royal Society of Chemistry
 The Royal Society of Chemistry Miscellaneous Commercial ServicesCommercial Services The Royal Society of Chemistry is an organization that supports the chemical sciences community in making the world a better place. The Royal Society of Chemistry is based in London, UK, and has subsidiaries in the United Kingdom. The British company offers various opportunities in education, inclusion, and chemistry's ability to tackle challenges. The organization aims to advance excellence, connect chemical scientists, and shape the future of the chemical sciences for the benefit of humanity. The private company has a publishing portfolio that contains over one million articles, chapters, and records from across the chemical sciences and related fields. The company also provides solutions to help businesses engage with their audience of chemical scientists. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Royal Academy of Engineering | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Waterloo | College/University | Graduate Degree | |
| University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
| Alma Mater Studiorum - Università di Bologna | College/University | Doctorate Degree | |
| London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
| Freie Universität Berlin | College/University | Graduate Degree | |
| London Business School | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin | |
| Imperial Consulting, Inc. | Director/Board Member Corporate Officer/Principal | ||
Novartis Institute for Functional Genomics, Inc.
 Novartis Institute for Functional Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institute For Functional Genomics, Inc. serves as a bridge between basic science and preclinical drug discovery for Novartis’ global research organization. Its focus areas include oncology, autoimmunity, cardiovascular disease, diabetes, musculoskeletal disorders, and infectious disease. The company was founded in 1999 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Bird Rock Bio, Inc.
 Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
| FRONTIER SMART TECHNOLOGIES GROUP LIMITED | Semiconductors | Chairman Chairman | |
The Royal Institution of Great Britain
 The Royal Institution of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Institution of Great Britain is a charitable organization that is dedicated to connecting people with the world of science. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | Biotechnology | Chairman Chief Executive Officer | |
Freeline Therapeutics Ltd.
 Freeline Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Freeline Therapeutics Ltd. operates as a biopharmaceutical company, which develops gene therapies for bleeding and other debilitating disorders. The company was founded by Chris Hollowood in 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
Blue Earth Diagnostics Ltd.
 Blue Earth Diagnostics Ltd. Medical/Nursing ServicesHealth Services Blue Earth Diagnostics Ltd. engages in the development and commercialization of positron emission tomography imaging agents. It focuses on the molecular imaging diagnostics. The company was founded in March 2014 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Chairman Director/Board Member | |
OMass Therapeutics Ltd.
 OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| AUTOLUS THERAPEUTICS PLC | Biotechnology | Director/Board Member Director/Board Member | |
Azeria Therapeutics Ltd.
 Azeria Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Azeria Therapeutics Ltd. engages in the research and development of pharmaceutical products. It develops treatments for hormone resistance that targets breast and prostate cancer patients. The company was founded by Jason Carroll in 2017 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Orbit Biomedical, Inc.
 Orbit Biomedical, Inc. Medical SpecialtiesHealth Technology Orbit Biomedical, Inc. engages in a healthcare company. It aims to revolutionize gene and cell therapy treatment by setting a new standard for precise, targeted surgical delivery. The company was founded by Mike Keane in 2018 and is headquartered in Ambler, PA.. | Medical Specialties | Director/Board Member | |
Anaveon AG
 Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
Gyroscope Therapeutics Ltd.
 Gyroscope Therapeutics Ltd. BiotechnologyHealth Technology Gyroscope Therapeutics Ltd. operates as an ophthalmology firm. It develops a cutting edge, genetically-defined therapies for the treatment of eye diseases linked to an unbalanced complement system. The company was founded on April 18, 2016 and is headquartered in Stevenage, the United Kingdom. | Biotechnology | Chairman Director/Board Member | |
Abu Dhabi Investment Office
 Abu Dhabi Investment Office Investment ManagersFinance Abu Dhabi Investment Office (ADIO) is a Venture Capital firm founded in 2018. Abu Dhabi Investment Office is headquartered in Abu Dhabi. | Investment Managers | Private Equity Investor | |
Quell Therapeutics Ltd.
 Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
Neogene Therapeutics, Inc.
 Neogene Therapeutics, Inc. BiotechnologyHealth Technology Neogene Therapeutics, Inc. engages in the provision T cell therapies to treat cancer. The company was founded by Ton N. M. Schumacher and Carsten Linnemann and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
L.E.K. Consulting Group Ltd.
 L.E.K. Consulting Group Ltd. Miscellaneous Commercial ServicesCommercial Services L.E.K. Consulting Group Ltd. operates as a management consulting firm. The company was founded on June 16,2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Analyst-Equity | |
Orbit Biomedical Ltd.
 Orbit Biomedical Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2018, Orbit Biomedical Ltd. is a British biotechnology company that engages in research and development. Part of Novartis AG, the company is based in Stevenage, UK. | Miscellaneous Commercial Services | Director/Board Member | |
SwanBio Therapeutics, Inc.
 SwanBio Therapeutics, Inc. BiotechnologyHealth Technology SwanBio Therapeutics, Inc. operates as a gene therapy firm. The company was founded by Tom Anderson, Rachel Salzman, Karen Kozarsky and Florian S. Eichler and is headquartered in Bala Cynwyd, PA. | Biotechnology | Chairman Chairman Director/Board Member | |
Resolution Therapeutics Ltd.
 Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| Forcefield Therapeutics Ltd. | Chairman Chief Executive Officer Director/Board Member Chief Executive Officer Director/Board Member |
Statistics
International
| United Kingdom | 33 |
| United States | 12 |
| Canada | 3 |
| Switzerland | 3 |
| Italy | 2 |
Sectoral
| Health Technology | 19 |
| Consumer Services | 15 |
| Commercial Services | 10 |
| Finance | 4 |
| Health Services | 3 |
Operational
| Director/Board Member | 234 |
| Corporate Officer/Principal | 128 |
| Chairman | 77 |
| Undergraduate Degree | 62 |
| Private Equity Investor | 57 |
Most connected contacts
| Insiders | |
|---|---|
| Richard Sykes | 37 |
| Martin Murphy | 33 |
| Ken Galbraith | 30 |
| Roel Bulthuis | 29 |
| Rachel Janis Lomax | 27 |
| Alice Gast | 22 |
| Bryan Geoffrey Morton | 22 |
| Chris Hollowood | 19 |
| Tariq bin Hendi | 16 |
| Hitesh Thakrar | 14 |
| Lisa Bright | 13 |
| Dominic Schmidt | 12 |
| David Wilbraham | 10 |
| Rolf Soderstrom | 10 |
| Martin Knight | 10 |
- Stock Market
- Insiders
- Michael Kyriakides
- Company connections
